Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.70 |
| ▸ | RAB9A | P51151 | 3/20 | 0.70 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.65 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.61 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.59 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.59 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.59 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.57 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | FAAH | O00519 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4376261 | 1.00 | MAPT (0.70) | MAPTRAB9APLA2G4BFFAR1S1PR1 | |
| SCHEMBL4361268 | 0.99 | MAPT (0.72) | MAPTRAB9APLA2G4BFFAR1S1PR1 | |
| SCHEMBL4364300 | 0.94 | MAPT (0.74) | MAPTRAB9APLA2G4BFFAR1S1PR1 | |
| SCHEMBL4361298 | 0.90 | MAPT (0.77) | MAPTRAB9AFFAR1NPC1SMN1; SMN2 | |
| SCHEMBL14966681 | 0.88 | MAPT (0.74) | MAPTRAB9AFFAR1S1PR1S1PR3 | |
| SCHEMBL24844734 | 0.88 | MAPT (0.90) | MAPTRAB9ANPC1SMN1; SMN2TDP1 | |
| SCHEMBL2404460 | 0.88 | CYP4A11 (0.73) | MAPTRAB9ACYP4A11CYP4F2NPC1 | |
| SCHEMBL7776764 | 0.88 | RAB9A (0.65) | MAPTRAB9AFFAR1S1PR1S1PR3 | |
| SCHEMBL9241409 | 0.87 | PLA2G4B (0.53) | MAPTRAB9APLA2G4BFFAR1S1PR1 | |
| SCHEMBL5054312 | 0.86 | MAPT (0.85) | MAPTRAB9APLA2G4BNPC1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1739071-B1 | METHOD FOR PRODUCING CARBOXYLIC ACID COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2012-06-06 | — | — | EP | disclosed |
| CN-100554236-C | The method for preparing carboxylic acid cpd | SUMITOMO CHEMICAL CO (JP) | 2009-10-28 | — | — | CN | disclosed |
| US-7511171-B2 | Method for producing carboxylic acid compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-03-31 | — | — | US | disclosed |
| US-20070197824-A1 | Method For Producing Carboxylic Acid Compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-08-23 | — | — | US | disclosed |
| CN-1938253-A | Process for producing carboxylic acid compound | SUMITOMO CHEMICAL CO (JP) | 2007-03-28 | — | — | CN | disclosed |
| EP-1739071-A1 | METHOD FOR PRODUCING CARBOXYLIC ACID COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2007-01-03 | — | — | EP | disclosed |
| CN-1082023-A | The medicine and the novel benzoic acid derivative that contain benzoic acid derivative | YAMANOUCHI PHARMA CO LTD (JP) | 1994-02-16 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070197824-A1 | Method For Producing Carboxylic Acid Compound | COASY, CA9, CA7 | MAPT 3874/4885RAB9A 1617/4885PLA2G4B 2371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.